Lonza’s latest paper on BioConjugates is published in OutSourced Pharma: De-Risking Your Bioconjugate’s Development Path From Discovery To The Clinic (outsourcedpharma.com)
By Raphael Frey, Team Lead, Early Development Bioconjugates; and Sandro Holzer, Head of Process Development, Bioconjugates, Lonza Pharma & Biotech
Let’s meet during our upcoming roadshow if you would like to have a tailored conversation with BioConjugates Subject Expert Matters. More information available here!